Radyalis Releases Next-Generation Monte Carlo Proton Therapy Planning

July 22, 2014 — Radyalis is showcasing its high-performance Monte Carlo dose calculation product for proton applications simultaneously at the 2014 annual meeting of the American Association of Physics in Medicine (AAPM) in Austin, Texas.

The company’s work in large-scale optimization and high-performance computing enables clinicians to utilize the high-accuracy benefits of Monte Carlo at unprecedented speeds for proton therapy dose modeling. The Monte Carlo engine changes radiotherapy workflow as the most complex patient treatment plans can be evaluated for efficacy and biological safety with high confidence in a matter of minutes.

The technology combines new algorithmic and software architecture advances for very high parallel efficiency on customer's existing hardware, including single and multiple node installations, clusters and cloud platforms, for both Linux and Windows environments. Radyalis software is highly portable and very flexible, and designed to be integrated via a customer API or into a treatment planner.

Without compromise, Monte Carlo supports a robust set of features. All relevant physics are accurately modeled. Simulation of complex geometries, NIST materials and multiple beams are fully supported. Radyalis provides sophisticated dosage statistics including particle distributions, variability, fluence and linear energy transfer, further guiding the radiation physicist.

The fast and accurate Monte Carlo dose calculator is a key enabler for next-generation treatment plan optimization, robust planning, quality assurance and ultimately real-time adaptive planning. The speed and accuracy of Radyalis' Monte Carlo product provides significant ROI advantages for equipment manufacturers, treatment centers and research organizations.

For more information: www.radyalis.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Therapy

June 19, 2024 — RaySearch Laboratories AB announced a milestone in radiotherapy technology where RaySearch’s RayStation ...

Time June 19, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
Subscribe Now